Literature DB >> 19116136

Transcription factor 8 activates R-Ras to regulate angiogenesis.

Takayuki Inuzuka1, Masumi Tsuda, Hideaki Kawaguchi, Yusuke Ohba.   

Abstract

We have recently reported that transcription factor 8 (TCF8) negatively regulates pathological angiogenesis by regulating endothelial invasiveness by acting as a transcriptional attenuator of matrix metalloproteinase 1. TCF8 also modulates cell-matrix and cell-cell adhesion; however molecular mechanism of this TCF8 function remains obscure. Here, we provide evidence that TCF8 activates R-Ras, another class of angiogenic regulator, to suppress angiogenesis by a mechanism other than a transcriptional attenuator. Tube formation by human umbilical vein endothelial cells (HUVECs) facilitated by TCF8 suppression was significantly inhibited by the expression of constitutive active mutant of R-Ras. When we examined the mRNA expression levels of R-Ras regulators, no significant changes were observed to explain the R-Ras activation by TCF8. Interestingly, we found that TCF8 bound to CalDAG-GEFIII, an R-Ras activator, in the cytosol, indicating that TCF8 emanates signaling for R-Ras activation from cytosol to regulate angiogenesis negatively.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19116136     DOI: 10.1016/j.bbrc.2008.12.101

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  14 in total

1.  miR-200b targets Ets-1 and is down-regulated by hypoxia to induce angiogenic response of endothelial cells.

Authors:  Yuk Cheung Chan; Savita Khanna; Sashwati Roy; Chandan K Sen
Journal:  J Biol Chem       Date:  2010-11-16       Impact factor: 5.157

2.  Effect of maternal undernutrition on vascular expression of micro and messenger RNA in newborn and aging offspring.

Authors:  O Khorram; G Han; R Bagherpour; T R Magee; M Desai; M G Ross; A A Chaudhri; T Toloubeydokhti; W J Pearce
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2010-03-03       Impact factor: 3.619

Review 3.  Regulatory networks defining EMT during cancer initiation and progression.

Authors:  Bram De Craene; Geert Berx
Journal:  Nat Rev Cancer       Date:  2013-02       Impact factor: 60.716

4.  RANKL expression specifically observed in vivo promotes epithelial mesenchymal transition and tumor progression.

Authors:  Tamaki Yamada; Masumi Tsuda; Tomomi Takahashi; Yasunori Totsuka; Masanobu Shindoh; Yusuke Ohba
Journal:  Am J Pathol       Date:  2011-05-10       Impact factor: 4.307

Review 5.  microRNA-200b as a Switch for Inducible Adult Angiogenesis.

Authors:  Mithun Sinha; Subhadip Ghatak; Sashwati Roy; Chandan K Sen
Journal:  Antioxid Redox Signal       Date:  2015-05-10       Impact factor: 8.401

6.  RALBP1/RLIP76 depletion in mice suppresses tumor growth by inhibiting tumor neovascularization.

Authors:  Seunghyung Lee; Jeremy G T Wurtzel; Sharad S Singhal; Sanjay Awasthi; Lawrence E Goldfinger
Journal:  Cancer Res       Date:  2012-08-17       Impact factor: 12.701

7.  The Ras-PI3K signaling pathway is involved in clathrin-independent endocytosis and the internalization of influenza viruses.

Authors:  Yoichiro Fujioka; Masumi Tsuda; Tomoe Hattori; Junko Sasaki; Takehiko Sasaki; Tadaaki Miyazaki; Yusuke Ohba
Journal:  PLoS One       Date:  2011-01-20       Impact factor: 3.240

8.  Tyr724 phosphorylation of ELMO1 by Src is involved in cell spreading and migration via Rac1 activation.

Authors:  Yoshinori Makino; Masumi Tsuda; Yusuke Ohba; Hiroshi Nishihara; Hirofumi Sawa; Kazuo Nagashima; Shinya Tanaka
Journal:  Cell Commun Signal       Date:  2015-07-25       Impact factor: 5.712

9.  Emerging treatments in lung cancer - targeting the RLIP76 molecular transporter.

Authors:  Lawrence E Goldfinger; Seunghyung Lee
Journal:  Lung Cancer (Auckl)       Date:  2013

10.  The ZEB1 transcription factor is a novel repressor of adiposity in female mice.

Authors:  Jessica N Saykally; Soner Dogan; Margot P Cleary; Michel M Sanders
Journal:  PLoS One       Date:  2009-12-24       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.